Menú

MARCEVAP
Malaltia, risc cardiovascular i estils de vida en atenció primària(MARCEVAP)

Responsable del grupo
MARCEVAP - Betlem_Salvador GONZALEZ
Betlem Salvador Gonzalez
bsalvador.apms.ics@gencat.cat
avatar_grups_recerca.png

Publicaciones

Chronic kidney disease progression in patients with previous type 2 diabetes and/or hypertension: a population-based cohort study from primary care in Spain.

O. CUNILLERA-PUERTOLAS, D. VIZCAYA, S. COBO-GUERRERO, J. ROMANO-SANCHEZ, D. BUNDO-LUQUE, A. ARBIOL-ROCA and B. SALVADOR-GONZALEZ
BMJ Open. 2025 Jan 20; . doi:10.1136/bmjopen-2024-086919; PMID:39832990

Ver más:
NSAIDs, analgesics, antiplatelet drugs, and decline in renal function: a retrospective case-control study with SIDIAP database

S. BONET-MONNÉ, C. URGELL, M. SÁEZ, O. PUERTOLÁS, J. BAENA-DÍEZ, J. PASCUAL, C. LAGO, J. RUIZ, B. GONZALEZ and R. PEDRÓS
BMC Pharmacology & Toxicology. 2024 Aug 28; . doi:10.1186/s40360-024-00771-5; PMID:39198874

Ver más:
Effectiveness of the low-density lipoprotein cholesterol goals in secondary cardiovascular prevention

M. GARCIA-GIL, L. ALVES-CABRATOSA, O. CUNILLERA, J. BLANCH, R. MARTÍ-LLUCH, A. PONJOAN, F. RIBAS-AULINAS, É. TORNABELL-NOGUERA, L. ZACARÍAS-PONS, G. DOMÍNGUEZ-ARMENGOL, E. GUZMÁN and R. RAMOS
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024 Jun 3; . doi:10.1111/eci.14258; PMID:38828496

Ver más:
Description of thyroid disorders the year before conception: a population-based study

G. VIVÓ, N. ESQUIUS, O. PUÉRTOLAS, M. RIERA, M. ALBALADEJO and L. BALLESTER
Frontiers in Endocrinology. 2023 Sep 25; . doi:10.3389/fendo.2023.1236505; PMID:37818089

Ver más:
Final Stage of Chronic Kidney Disease with Conservative Kidney Management or Renal Replacement Therapy: A Primary-Care Population Study

D. BUNDÓ, O. CUNILLERA, A. ARBIOL-ROCA, S. COBO-GUERRERO, J. ROMANO, N. GIL-TERRON, X. FULLADOSA, J. COMAS, I. RAMA, J. CRUZADO and B. SALVADOR-GONZALEZ
Journal of Clinical Medicine. 2023 Jul 1; . doi:10.3390/jcm12144602; PMID:37510717

Ver más: